Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Change in Accured Expenses (2020 - 2026)

Bioventus filings provide 6 years of Change in Accured Expenses readings, the most recent being -$4.4 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 126.74% to -$4.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$19.8 million, a 211.03% decrease, with the full-year FY2025 number at -$19.8 million, down 211.03% from a year prior.
  • Change in Accured Expenses hit -$4.4 million in Q4 2025 for Bioventus, down from $7.3 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $29.9 million in Q2 2024 to a low of -$39.1 million in Q1 2025.
  • Median Change in Accured Expenses over the past 5 years was $5.1 million (2021), compared with a mean of $393450.0.
  • Biggest five-year swings in Change in Accured Expenses: surged 862.23% in 2021 and later crashed 911.94% in 2022.
  • Bioventus' Change in Accured Expenses stood at $11.0 million in 2021, then skyrocketed by 30.53% to $14.3 million in 2022, then plummeted by 59.53% to $5.8 million in 2023, then soared by 186.98% to $16.6 million in 2024, then tumbled by 126.74% to -$4.4 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$4.4 million (Q4 2025), $7.3 million (Q3 2025), and $16.4 million (Q2 2025) per Business Quant data.